Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics
NCT01210755
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Venous Thromboembolism
Interventions
DRUG:
Rivaroxaban, Dabigatran
DRUG:
Dabigatran; Rivaroxaban
Sponsor
University Hospital, Grenoble